Skip to content
★ Sign in to follow
GL

Gerald L. Jensen

TherapeuticsMD, Inc.
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€23k
▼ Sales (0 ops.)
—

Latest filing published 23 Aug 2007 for TherapeuticsMD, Inc., €904.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8
Positive at T+90
0%
Median T+90
-30.0%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 23 Aug 2007 · 7018 days ago · €904
    -39.6%
    Entry US$4,166.67 · Close at T+365 US$2,516.67
  • Filed 01 Aug 2007 · 7040 days ago · €327
    -39.6%
    Entry US$4,166.67 · Close at T+365 US$2,516.67
  • Filed 14 Jun 2007 · 7088 days ago · €741
    -20.0%
    Entry US$4,166.67 · Close at T+365 US$3,333.33

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gerald L. Jensen: trading record in brief

Gerald L. Jensen discloses dealings in TherapeuticsMD, Inc. to SEC (Form 4). The record holds 8 filings, for trades running from 5 March 2006 to 16 August 2007.

Every open-market trade on record is a purchase: 8 purchases worth €23k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2007, the count stands at 7 purchases and no sales.

A typical purchase (the median) is worth €1,524. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -30.0%. This is a record of the past, not a forecast.

The record was last updated on 23 August 2007 with an open-market purchase (€904) in TherapeuticsMD, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Gerald L. Jensen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    1,220 USD0SEC
    464 shares@ US$2.63Croff Enterprises, Inc. Common SharesSEC:0001263371-07-000010:0
    Canonical exit: 14 Nov 2007 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    448 USD0SEC
    161 shares@ US$2.78Croff enterprises, inc common shareSEC:0001263371-07-000009:0
    Canonical exit: 29 Oct 2007 (T+90)
  • ▲
    PRESIDENTExecutivesTherapeuticsMD, Inc.
    986 USD0SEC
    375 shares@ US$2.63CROFF ENTERPRISES, INC.SEC:0001263371-07-000008:0
    Canonical exit: 11 Sept 2007 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    2,630 USD0SEC
    1,000 shares@ US$2.63Croff Enterprises, Inc.SEC:0001263371-07-000007:0
    Canonical exit: 3 Jun 2006 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    2,630 USD0SEC
    1,000 shares@ US$2.63Croff Enterprises, Inc. Common SharesSEC:0001263371-07-000006:0
    Canonical exit: 29 May 2007 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    1,435 USD0SEC
    500 shares@ US$2.87Croff Enterprise, Inc.SEC:0001263371-07-000005:0
    Canonical exit: 22 May 2007 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    2,543 USD0SEC
    880 shares@ US$2.89Croff Enterprises, Inc. Common SharesSEC:0001214659-07-000355:0
    Canonical exit: 10 May 2007 (T+90)
  • ▲
    PresidentExecutivesTherapeuticsMD, Inc.
    17,817 USD0SEC
    5,939 shares@ US$3.00Croff Enterprises, Inc Class B Preferred SharesSEC:0000025743-06-000007:0
    Canonical exit: 13 Aug 2006 (T+90)

8 of 8 declarations